163 related articles for article (PubMed ID: 35321278)
1. Computed tomography-based radiomic to predict resectability in locally advanced pancreatic cancer treated with chemotherapy and radiotherapy.
Rossi G; Altabella L; Simoni N; Benetti G; Rossi R; Venezia M; Paiella S; Malleo G; Salvia R; Guariglia S; Bassi C; Cavedon C; Mazzarotto R
World J Gastrointest Oncol; 2022 Mar; 14(3):703-715. PubMed ID: 35321278
[TBL] [Abstract][Full Text] [Related]
2. CT radiomic features for predicting resectability of oesophageal squamous cell carcinoma as given by feature analysis: a case control study.
Ou J; Li R; Zeng R; Wu CQ; Chen Y; Chen TW; Zhang XM; Wu L; Jiang Y; Yang JQ; Cao JM; Tang S; Tang MJ; Hu J
Cancer Imaging; 2019 Oct; 19(1):66. PubMed ID: 31619297
[TBL] [Abstract][Full Text] [Related]
3. Predictive value of 0.35 T magnetic resonance imaging radiomic features in stereotactic ablative body radiotherapy of pancreatic cancer: A pilot study.
Simpson G; Spieler B; Dogan N; Portelance L; Mellon EA; Kwon D; Ford JC; Yang F
Med Phys; 2020 Aug; 47(8):3682-3690. PubMed ID: 32329904
[TBL] [Abstract][Full Text] [Related]
4. Development and Validation of a Computed Tomography-Based Radiomics Signature to Predict Response to Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer.
Wang W; Peng Y; Feng X; Zhao Y; Seeruttun SR; Zhang J; Cheng Z; Li Y; Liu Z; Zhou Z
JAMA Netw Open; 2021 Aug; 4(8):e2121143. PubMed ID: 34410397
[TBL] [Abstract][Full Text] [Related]
5. Computed tomography-based radiomic analysis for predicting pathological response and prognosis after neoadjuvant chemotherapy in patients with locally advanced esophageal cancer.
Oda S; Kuno H; Hiyama T; Sakashita S; Sasaki T; Kobayashi T
Abdom Radiol (NY); 2023 Aug; 48(8):2503-2513. PubMed ID: 37171586
[TBL] [Abstract][Full Text] [Related]
6. Multi-modal radiomics model to predict treatment response to neoadjuvant chemotherapy for locally advanced rectal cancer.
Li ZY; Wang XD; Li M; Liu XJ; Ye Z; Song B; Yuan F; Yuan Y; Xia CC; Zhang X; Li Q
World J Gastroenterol; 2020 May; 26(19):2388-2402. PubMed ID: 32476800
[TBL] [Abstract][Full Text] [Related]
7. Integrating CT-based radiomic model with clinical features improves long-term prognostication in high-risk prostate cancer.
Ching JCF; Lam S; Lam CCH; Lui AOY; Kwong JCK; Lo AYH; Chan JWH; Cai J; Leung WS; Lee SWY
Front Oncol; 2023; 13():1060687. PubMed ID: 37205204
[TBL] [Abstract][Full Text] [Related]
8. Training and validation of a robust PET radiomic-based index to predict distant-relapse-free-survival after radio-chemotherapy for locally advanced pancreatic cancer.
Mori M; Passoni P; Incerti E; Bettinardi V; Broggi S; Reni M; Whybra P; Spezi E; Vanoli EG; Gianolli L; Picchio M; Di Muzio NG; Fiorino C
Radiother Oncol; 2020 Dec; 153():258-264. PubMed ID: 32681930
[TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance imaging radiomics predicts preoperative axillary lymph node metastasis to support surgical decisions and is associated with tumor microenvironment in invasive breast cancer: A machine learning, multicenter study.
Yu Y; He Z; Ouyang J; Tan Y; Chen Y; Gu Y; Mao L; Ren W; Wang J; Lin L; Wu Z; Liu J; Ou Q; Hu Q; Li A; Chen K; Li C; Lu N; Li X; Su F; Liu Q; Xie C; Yao H
EBioMedicine; 2021 Jul; 69():103460. PubMed ID: 34233259
[TBL] [Abstract][Full Text] [Related]
10. Predictive value of computed tomography on surgical resectability in locally advanced pancreatic cancer treated with multiagent induction chemotherapy: Results from a prospective, multicentre phase 2 trial (NEOLAP-AIO-PAK-0113).
Guggenberger KV; Bley TA; Held S; Keller R; Flemming S; Wiegering A; Germer CT; Kimmel B; Kunzmann V; Hartlapp I; Anger F
Eur J Radiol; 2023 Jun; 163():110834. PubMed ID: 37080059
[TBL] [Abstract][Full Text] [Related]
11. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.
Sun R; Limkin EJ; Vakalopoulou M; Dercle L; Champiat S; Han SR; Verlingue L; Brandao D; Lancia A; Ammari S; Hollebecque A; Scoazec JY; Marabelle A; Massard C; Soria JC; Robert C; Paragios N; Deutsch E; Ferté C
Lancet Oncol; 2018 Sep; 19(9):1180-1191. PubMed ID: 30120041
[TBL] [Abstract][Full Text] [Related]
12. Predicting Pathological Response to Preoperative Chemotherapy in Pancreatic Ductal Adenocarcinoma Using Post-Chemotherapy Computed Tomography Radiomics.
Ikuta S; Aihara T; Nakajima T; Yamanaka N
Cureus; 2024 Jan; 16(1):e52193. PubMed ID: 38348011
[TBL] [Abstract][Full Text] [Related]
13. Multiphase computed tomography radiomics of pancreatic intraductal papillary mucinous neoplasms to predict malignancy.
Polk SL; Choi JW; McGettigan MJ; Rose T; Ahmed A; Kim J; Jiang K; Balagurunathan Y; Qi J; Farah PT; Rathi A; Permuth JB; Jeong D
World J Gastroenterol; 2020 Jun; 26(24):3458-3471. PubMed ID: 32655269
[TBL] [Abstract][Full Text] [Related]
14. Treatment planning computed tomography radiomics for predicting treatment outcomes and haematological toxicities in locally advanced cervical cancer treated with radiotherapy: A retrospective cohort study.
Ren K; Shen L; Qiu J; Sun K; Chen T; Xuan L; Yang M; She HY; Shen L; Zhu H; Deng L; Jing D; Shi L
BJOG; 2023 Jan; 130(2):222-230. PubMed ID: 36056595
[TBL] [Abstract][Full Text] [Related]
15. How to approach pancreatic cancer after neoadjuvant treatment: assessment of resectability using multidetector CT and tumor markers.
Jeon SK; Lee JM; Lee ES; Yu MH; Joo I; Yoon JH; Jang JY; Lee KB; Lee SH
Eur Radiol; 2022 Jan; 32(1):56-66. PubMed ID: 34170366
[TBL] [Abstract][Full Text] [Related]
16. Prediction of Response to Preoperative Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancer Using Multicenter CT-Based Radiomic Analysis.
Tian X; Sun C; Liu Z; Li W; Duan H; Wang L; Fan H; Li M; Li P; Wang L; Liu P; Tian J; Chen C
Front Oncol; 2020; 10():77. PubMed ID: 32117732
[No Abstract] [Full Text] [Related]
17. Integrative nomogram of intratumoral, peritumoral, and lymph node radiomic features for prediction of lymph node metastasis in cT1N0M0 lung adenocarcinomas.
Das SK; Fang KW; Xu L; Li B; Zhang X; Yang HF
Sci Rep; 2021 May; 11(1):10829. PubMed ID: 34031529
[TBL] [Abstract][Full Text] [Related]
18.
Li P; Wang X; Xu C; Liu C; Zheng C; Fulham MJ; Feng D; Wang L; Song S; Huang G
Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1116-1126. PubMed ID: 31982990
[TBL] [Abstract][Full Text] [Related]
19. Development of a Radiotherapy Localisation Computed Tomography-Based Radiomic Model for Predicting Survival in Patients With Nasopharyngeal Carcinoma Treated With Intensity-Modulated Radiotherapy Following Induction Chemotherapy.
Li X; Chen H; Zhao F; Zheng Y; Pang H; Xiang L
Cancer Control; 2022; 29():10732748221076820. PubMed ID: 35271403
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcomes of induction chemotherapy and neoadjuvant stereotactic body radiotherapy for borderline resectable and locally advanced pancreatic adenocarcinoma.
Mellon EA; Hoffe SE; Springett GM; Frakes JM; Strom TJ; Hodul PJ; Malafa MP; Chuong MD; Shridhar R
Acta Oncol; 2015 Jul; 54(7):979-85. PubMed ID: 25734581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
